Neurological Treatment of Epilepsy Flashcards
What is epilepsy?
The tendency to have recurrent epileptic seizures (not one disease process)
What are epileptic seizures?
Abnormal, synchronous firing of a large number of cortical neurons, causing symptoms
(Fundamentally abnormal as most actions use spare coding = strong activation from small set of neurons)
What poorer outcomes are associated with epilepsy?
▪️ Education
▪️ Employment
▪️ Mental health
▪️ Stigma
▪️ Injury and mortality
▪️ Unplanned hospital admissions
What are the eight steps of the NICE neurological management pathway for epilepsy?
- Patient presents with suspected seizure(s)
- History, examination, and investigations
- Diagnosis and classification
- Explanation, discussion, provision of info
- Decision to treat
- Ongoing treatment
- Possible referral to tertiary service depending on response/outcome
- Stopping treatment
What usually happens after an individual presents to their GP/A&E with suspected seizure(s)?
They are referred to a specialist for diagnosis and decision to start treatment, ideally within 2 weeks
Why is the aim to get patients with suspected seizure(s) seen by a specialist within 2 weeks?
This follows the cancer pathway due to the possibility of a tumour
What investigations might be ordered by an epilepsy specialist?
▪️ EEG
▪️ ECG
▪️ Neuroimaging
▪️ Neuropsychological assessment
▪️ Blood test
What information does the NICE guidelines say should be provided to people with epilepsy?
▪️ Epilepsy in general (incl. treatment options, types and triggers, SUDEP, status epilepticus)
▪️ Risk management
▪️ Psychological issues
▪️ Education and employment
▪️ Road safety and driving
▪️ Lifestyle (incl. alcohol, sleep deprivation)
▪️ Issues relevant to women
▪️ Voluntary organisations
What should drug treatment for epilepsy be individualised to?
▪️ Seizure type
▪️ Epilepsy syndrome
▪️ Co-medication
▪️ Co-morbidity
▪️ Lifestyle
▪️ Preferences
What should be tried if a single AED is not successful in controlling seizures?
Another drug should be tried as monotherapy
When should combination therapy (polytherapy) be considered?
When monotherapy with more than one AED has not resulted in seizure freedom
What risk should be considered when prescribing sodium valproate to a woman?
Risk of malformation and neurodevelopmental impairments in an unborn child
When is SUDEP most likely to occur and why?
During sleep likely due to suppression of brain stem autonomic processes (e.g., decreased HR and breathing)
How many antiepileptic drugs are currently available in the UK?
25
What are the main issues with the evidence base for which AED to prescribe?
▪️ Only “newer” drugs have gone through RCTs in comparison to placebos
▪️ Trials mostly in difficult-to-treat, chronic patients in addition to current therapy
▪️ Very few comparative trials, mostly in new-onset treatment naïve epilepsy
▪️ Very little evidence for polytherapy
What did Kwan and Brodie (2000) find when comparing monotherapy to polytherapy?
▪️ Most people become seizure free with monotherapy, usually with the first drug tried
▪️ No evidence that any particular drug was preferable
▪️ Outcome predicted by “idiopathic” aetiology and fewer seizures before treatment
What was the SANAD trial?
A large RCT investigating the effectiveness of standard and new epileptic drugs in partial (focal-onset) seizures and generalised/unclassifiable seizures
(Sodium valproate vs topiramate, lamotrigine, carbamazepine, and gabapentin)
What did the SANAD trial find in regards to generalised or unclassifiable seizures?
▪️ Valproate was better tolerated than topiramate and more efficacious than lamotrigine
▪️ BUT must not adverse effects in pregnancy
What did the SANAD trial find in regards to patial (focal) seizures?
▪️ Lamotrigine = better tolerated than carbamazepine and equally efficacious
▪️ Lamotrigine = better tolerated than topiramate but both better than gabapentin
What were the two arms of the SANAD II trial?
A) Lamotrigine vs levetiracetam vs zonisamide in untreated focal onset seizures
B) Levetiracetam vs valproate in untreated generalised onset/unclassifiable seizures